Bipolar Disorders: Mixed States, Rapid-Cycling, and Atypical Forms

350 J. Cookson and S. GhalibPeroutka, S. J. and Snyder, S. H. (1980). Relationship of neuroleptic drug effects at brain dopamine,serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am.J.Psychiatry,137, 1518–22.Perugi, G., Akiskal, H. S., Micheli, C., et al. (1997). Clinical subtypes of bipolar mixed states:validating a broader European definition in 143 cases. J. Affect. Disord., 43, 169–80.Perugi, G., Micheli, C., Akiskal, H. S., et al. (2000). Polarity of the first episode, clinicalcharacteristics, and course of manic depressive illness: a systematic retrospective investigationof 320 bipolar I patients. Comp. Psychiatry, 41, 13–18.Perugi, G., Maremmani, I., Toni, C., et al. (2001). The contrasting influence of depressive andhyperthymic temperaments on psychometrically derived manic subtypes. Psychiatry Res.,101, 249–58.Pope, H. G., McElroy, S. L., Keck, P. E., and Hudson, J. I. (1991). Valproate in the treatment ofacute mania: a placebo-controlled study. Arch. Gen. Psychiatry, 48, 62–8.Post, R. N., Lake, C. R., Jimerson, D. R., et al. (1978). Cerebrospinal fluid norepinephrine inaffective illness. Am. J. Psychiatry, 135, 907–12.Post, R. M., Ballenger, J. C., Rey, A. C., and Bunney, W. E. Jr. (1981). Slow and rapid onset ofmanic episodes: implications for underlying biology. Psychiatry Res., 4, 229–37.Post, R. M., Uhde, T. W., Roy-Byrne, P. P., and Joffe, R. T. (1987). Correlates of antimanicresponses to carbamazepine. Psychiatry Res., 21, 71–83.Post, R. M., Rubinow, D. R., Uhde, T. W., et al. (1989). Dysphoric mania. Clinical and biologicalcorrelates. Arch. Gen. Psychiatry, 46, 353–8.Prien, R. F., Caffey, E. M., and Klett, C. J. (1972). Comparison of lithium carbonate andchlorpromazine in the treatment of mania. Arch. Gen. Psychiatry, 26, 146–53.Prien, R. F., Himmelhoch, J. M., and Kupfer, D. J. (1988). Treatment of mixed mania. J. Affect.Disord., 15, 9–15.Quitkin, F. M., Kane, J., Rifkin, A. et al. (1981). Prophylactic lithium carbonate with and withoutimipramine for bipolar 1 patient: a double-blind study. Arch. Gen. Psychiatry, 38, 902–7.Quitkin, F. M., Rabkin, J. G., and Prien, R. F. (1986). Bipolar disorder: are there manic-proneand depressive-prone forms? J. Clin. Psychopharmacol., 6, 167–72.Rees, L., Butler, P. W. P., Gossling, C., et al. (1970). Adrenergic blockade and the corticosteroidand growth hormone response to methyl-amphetamine. Nature, 228, 565–6.Reichart, C. G., Nolen, W. A., Wals, M., and Hillegers, M. H. J. (2000). Bipolar disorder inchildren and adolescents: a clinical reality? Acta Neuropsychiatrica, 12, 132–5.Rottanburg, D., Robins, A. H., Ben-Arie, O., Teggin, A., and Elk, R. (1982). Cannabis-associatedpsychosis with manic features. Lancet, ii, 1364–6.Secunda, S. K., Katz, M. M., Swann, A. C., et al. (1987a). Mania: diagnosis, state measurementand prediction of treatment response. J. Affect. Disord., 8, 113–21.Secunda, S. K., Swann, A. C., and Katz, M. M. (1987b). Diagnosis and treatment of mixed mania.Am. J. Psychiatry., 144, 96–8.Shulman, K. I. and Post, F. (1980). Bipolar affective disorder in old age. Br.J.Psychiatry,136, 26–32.Shulman, K. I., Schaffer, Y., Levitt, A., and Herrmann, N. (2002). Effects of gender and ageon phenomenology and management of bipolar disorder: a review. In Bipolar Disorder, ed.